Akari Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.05.24	Akari Therapeutics Appoints Samir Patel Interim CEO After CEO Rachelle Jacques Steps Down (RTTNews)
05.03.24	Akari Therapeutics, Peak Bio Announces Agreement To Merge As Equals - Quick Facts (RTTNews)
21.07.22	ABT Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6% (RTTNews)
06.10.20	Akari Therapeutics Reports Continued Progress In COVID-19 Pneumonia Program With Nomacopan (RTTNews)
01.07.20	Stock Alert: Akari Therapeutics Up 7% (RTTNews)
11.10.19	5 Top Losers In Healthcare Sector (AKTX, COCP, AUPH…) (RTTNews)
16.08.19	5 Top Losers In Healthcare Sector (JAGX, HROW, IVC…) (RTTNews)
24.04.19	6 Top Gainers In Healthcare Sector (ATOS, AKTX, ATHX...) (RTTNews)
16.04.19	AXSM Has Had An Awesome Run. What Awaits These 13 Biotech Stocks In Q2, 2019? (RTTNews)
14.03.19	8 Top Gainers In Healthcare Sector (AKTX, GH, HJLI...) (RTTNews)
26.06.18	XBIO Explodes Over 100%, ZFGN Abuzz, NTRA Grabs Investors' Attention (RTTNews)
19.10.17	FDA Blesses 2nd CAR-T Cell Therapy, NVO One Step Away From Approval, AKTX Slumps (RTTNews)
26.09.17	ACRX Nearing 'Big Day', No Respite For VSAR, ARDM To Face FDA (RTTNews)
31.07.17	How These Generic Drugs Stocks are Performing? -- Akari Therapeutics, Flexion Therapeutics, Lannett, and Supernus Pharma (PR Newswire)
08.07.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akari Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - AKTX (PR Newswire)
05.07.17	EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akari Therapeutics, Plc - AKTX (PR Newswire)
03.06.17	AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action... (PR Newswire)
01.06.17	URGENT: Monteverde & Associates PC Invites Akari Therapeutics, Plc. Shareholders with Significant Losses To Contact The Firm Immediately - AKTX (PR Newswire)
30.05.17	Lifshitz & Miller LLP Announces Investigation of Akari Therapeutics, Plc, Alexion Pharmaceuticals, Inc., Amgen Inc., Cel-Sci Corp., Dick's Sporting Goods, Inc., Eco Science Solutions, Inc. (PR Newswire)
23.05.17	Investor Alert: Kaplan Fox Announces Investigation Of Akari Therapeutics, PLC (PR Newswire)
23.05.17	IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm (PR Newswire)
22.05.17	AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm (PR Newswire)
19.05.17	IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm (PR Newswire)
19.05.17	How These Generic Drugs Stocks are Faring? -- MYOS RENS Technology, Akari Therapeutics, Flexion Therapeutics, and Zynerba Pharma (PR Newswire)
18.05.17	IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm (PR Newswire)
18.05.17	SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 (PR Newswire)
12.05.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akari Therapeutics plc - AKTX (PR Newswire)
12.05.17	AKARI INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akari Therapeutics, Plc To Contact The Firm (PR Newswire)
12.05.17	AKTX Falls To Disgrace, CATB Awaits Data In Q3, CORI Surges On Trial Data (RTTNews)
25.04.17	Gainers & Losers Of Apr.24: PZRX, BCR, IMNP, ACHN, AKTX... (RTTNews)
24.04.17	MÄRKTE USA/Frankreich-Wahl und Steuerfantasie treiben Kurse (Dow Jones)
24.04.17	Akari Gets Great News On Blood Disease Drug (RTTNews)
24.04.17	MÄRKTE USA/Wall Street von Frankreich und Steuerreform beflügelt (Dow Jones)
24.04.17	MÄRKTE USA/Wall Street von Frankreich und Steuerreform beflügelt (Dow Jones)
21.04.17	Gainers & Losers Of Apr.20: IMNP, AKTX, IMGN, ALDX, KMPH... (RTTNews)
20.04.17	Gainers & Losers Of Apr.19: SNGX, IMGN, CBLI, SSH, AKTX... (RTTNews)
19.04.17	Gainers & Losers Of Apr.18: XOMA, AKTX, CYTK, AGIO, SRNE... (RTTNews)
18.04.17	Gainers & Losers Of Apr.17: CBLI, INFI, PBYI, OMED, INCY... (RTTNews)
12.04.17	Gainers & Losers Of Apr.11: WINT, GNCA, MESO, CYTX, ENDP... (RTTNews)
07.04.17	Company Spotlight: Akari Therapeutics (RTTNews)
07.04.17	Gainers & Losers Of Apr.6: HTGM, AKTX, FGEN, ARLZ, ADAP... (RTTNews)
31.03.17	AEZS One Step Closer, AKTX To Report Data In April, CBIO On The Move (RTTNews)
01.02.17	Gainers & Losers Of The Day: MNTA, BLCM, VSAR, TENX, DMTX... (RTTNews)
25.01.17	Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA... (RTTNews)
14.07.16	NVCR Up On FDA Nod, PeriCoach Now Available OTC, FDA Panel Backs GP2015 (RTTNews)
23.05.16	Akari: Coversin Gets Positive Opinion For Orphan Drug Designation In EU For GBS (RTTNews)
01.04.16	GNCA Zooms On Herpes Study Results, HART Is Now BSTG, More In Store For RDHL (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	79.88	2.70 %	K V
Roche Hldg G	264.40	2.68 %	K V
Lonza Grp	554.20	2.29 %	K V
Swiss Re	134.85	1.70 %	K V
Novartis	90.39	1.61 %	K V
ABB	49.48	-0.26 %	K V
Geberit	513.60	-0.35 %	K V
Sika	216.90	-0.37 %	K V
Kuehne+Nagel Int	208.50	-0.43 %	K V
Holcim	88.08	-0.45 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Akari Therapeutics PLC (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten